These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26675062)

  • 1. Lung Size and the Risk of Radiation Pneumonitis.
    Briere TM; Krafft S; Liao Z; Martel MK
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):377-84. PubMed ID: 26675062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
    Willner J; Jost A; Baier K; Flentje M
    Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the relationship between gross tumor volume location and pneumonitis rates using a large clinical database of non-small-cell lung cancer patients.
    Vinogradskiy Y; Tucker SL; Liao Z; Martel MK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1650-8. PubMed ID: 21497454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.
    Seppenwoolde Y; Lebesque JV; de Jaeger K; Belderbos JS; Boersma LJ; Schilstra C; Henning GT; Hayman JA; Martel MK; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):724-35. PubMed ID: 12573760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting pneumonitis risk: a dosimetric alternative to mean lung dose.
    Tucker SL; Mohan R; Liengsawangwong R; Martel MK; Liao Z
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):522-7. PubMed ID: 22580121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
    Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
    Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
    Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-small cell lung cancer: risk factors of radiation pneumonitis].
    Giroux Leprieur E; Fernandez D; Chatellier G; Klotz S; Giraud P; Durdux C
    Cancer Radiother; 2012; 16(4):257-62. PubMed ID: 22748977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
    Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
    Yorke ED; Jackson A; Rosenzweig KE; Braban L; Leibel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):672-82. PubMed ID: 15939548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy.
    Yorke ED; Jackson A; Rosenzweig KE; Merrick SA; Gabrys D; Venkatraman ES; Burman CM; Leibel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):329-39. PubMed ID: 12243805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
    Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy.
    Tsougos I; Nilsson P; Theodorou K; Kjellén E; Ewers SB; Jarlman O; Lind BK; Kappas C; Mavroidis P
    Phys Med Biol; 2007 Feb; 52(4):1055-73. PubMed ID: 17264370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.
    Kong FM; Hayman JA; Griffith KA; Kalemkerian GP; Arenberg D; Lyons S; Turrisi A; Lichter A; Fraass B; Eisbruch A; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1075-86. PubMed ID: 16647222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk Than Mean Lung Dose: Secondary Analysis of a Randomized Trial.
    Tucker SL; Xu T; Paganetti H; Deist T; Verma V; Choi N; Mohan R; Liao Z
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):403-410. PubMed ID: 30291994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis.
    Tucker SL; Li M; Xu T; Gomez D; Yuan X; Yu J; Liu Z; Yin M; Guan X; Wang LE; Wei Q; Mohan R; Vinogradskiy Y; Martel M; Liao Z
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):251-7. PubMed ID: 22541966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC).
    Graham MV; Purdy JA; Emami B; Harms W; Bosch W; Lockett MA; Perez CA
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):323-9. PubMed ID: 10487552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.